MACHIORLATTI M[au] - Search Results

Year	Number of Results
2014	2
2016	2
2017	2
2018	2
2019	3
2020	4
2022	3
2023	2

1

Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.

Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O'Connor DJ, Méndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM. Wang Z, et al. Among authors: machiorlatti m. Nat Med. 2019 Jan;25(1):141-151. doi: 10.1038/s41591-018-0221-5. Epub 2018 Nov 12. Nat Med. 2019. PMID: 30420753 Free PMC article.

2

Patterns of Colorectal Cancer in Texas Counties From 2000 to 2017.

LaPelusa M, Diaz F, Machiorlatti M. LaPelusa M, et al. Among authors: machiorlatti m. JCO Oncol Pract. 2022 May;18(5):e770-e779. doi: 10.1200/OP.22.00093. JCO Oncol Pract. 2022. PMID: 35544648

3

Factors associated with meeting physical activity guidelines during the COVID-19 pandemic.

Heredia NI, Machiorlatti M, Reininger BM, Robledo C. Heredia NI, et al. Among authors: machiorlatti m. BMC Public Health. 2022 Nov 25;22(1):2178. doi: 10.1186/s12889-022-14613-8. BMC Public Health. 2022. PMID: 36434630 Free PMC article.

4

Factors Contributing to SARS-CoV-2 Vaccine Hesitancy of Hispanic Population in Rio Grande Valley.

Bikaki A, Machiorlatti M, Clark LC, Robledo CA, Kakadiaris IA. Bikaki A, et al. Among authors: machiorlatti m. Vaccines (Basel). 2022 Aug 9;10(8):1282. doi: 10.3390/vaccines10081282. Vaccines (Basel). 2022. PMID: 36016170 Free PMC article.

5

Disparity in outcomes of melanoma adjuvant immunotherapy by demographic profile.

Ikeguchi A, Machiorlatti M, Vesely SK. Ikeguchi A, et al. Among authors: machiorlatti m. Melanoma Manag. 2020 Jul 16;7(2):MMT43. doi: 10.2217/mmt-2020-0002. Melanoma Manag. 2020. PMID: 32821375 Free PMC article.

6

Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy.

Assi HA, Asch AS, Machiorlatti M, Vesely SK, Ibrahimi S. Assi HA, et al. Among authors: machiorlatti m. Future Sci OA. 2020 Jun 25;6(7):FSO581. doi: 10.2144/fsoa-2020-0021. Future Sci OA. 2020. PMID: 32802390 Free PMC article.

7

Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study.

Mukherjee S, Ibrahimi S, Machiorlatti M, Roman D, Saleem R, Hassan A, Baxley A, Vesely S, Aljumaily R. Mukherjee S, et al. Among authors: machiorlatti m. Am J Ther. 2018 Nov/Dec;25(6):e767-e768. doi: 10.1097/MJT.0000000000000774. Am J Ther. 2018. PMID: 29746291 No abstract available.

8

Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database.

Assi HA, Mukherjee S, Machiorlatti M, Vesely S, Pareek V, Hatoum H. Assi HA, et al. Among authors: machiorlatti m. Anticancer Res. 2020 Feb;40(2):847-855. doi: 10.21873/anticanres.14017. Anticancer Res. 2020. PMID: 32014928

9

Physician's Knowledge and Practices Surrounding Low-Dose Aspirin for Preeclampsia Risk Reduction.

Martinez-King LC, Machiorlatti M, Ogburn T, Salcedo J. Martinez-King LC, et al. Among authors: machiorlatti m. Am J Perinatol. 2023 Jan 17. doi: 10.1055/a-1990-2728. Online ahead of print. Am J Perinatol. 2023. PMID: 36452971

10

Socioeconomic differences in nicotine exposure and dependence in adult daily smokers.

Chen A, Machiorlatti M, Krebs NM, Muscat JE. Chen A, et al. Among authors: machiorlatti m. BMC Public Health. 2019 Apr 3;19(1):375. doi: 10.1186/s12889-019-6694-4. BMC Public Health. 2019. PMID: 30943945 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results